Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kunanusont

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
American Journal of Preventive Medicine|September 18, 1999
The Asian Pacific Economic Cooperation Emerging Infections NetworkA M Kimball, C A Horwitch, P W O'Carroll, et al.
AIDS (London, England)|August 10, 2000
A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patientsK Ruxrungtham, E D Kroon, C Ungsedhapand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2001
A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patientsC Ungsedhapand, E D Kroon, S Suwanagool, et al.
AIDS (London, England)|August 10, 2000
A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research CollaborationE D Kroon, C Ungsedhapand, K Ruxrungtham, et al.
AIDS (London, England)|January 11, 2000
A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in ThailandK Ruxrungtham, S Suwanagool, J A Tavel, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
American Journal of Preventive Medicine|September 18, 1999
The Asian Pacific Economic Cooperation Emerging Infections NetworkA M Kimball, C A Horwitch, P W O'Carroll, et al.
AIDS (London, England)|August 10, 2000
A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patientsK Ruxrungtham, E D Kroon, C Ungsedhapand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2001
A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patientsC Ungsedhapand, E D Kroon, S Suwanagool, et al.
AIDS (London, England)|August 10, 2000
A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research CollaborationE D Kroon, C Ungsedhapand, K Ruxrungtham, et al.
AIDS (London, England)|January 11, 2000
A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in ThailandK Ruxrungtham, S Suwanagool, J A Tavel, et al.
Pageof 2